chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal, No adverse reaction
Clinical narrative: Information has been received from a physician concerning a female with no pertinent medical history and no drug reactions/allergies who, "as a child", was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). There was no concomitant medication. In junior high school, the patient "showed low titer". The patient was revaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). In approximately July 2006, at 19-years-old, the patient was tested prior to working and was found to have low titers again. No further information was available. Unspecified medical attention was sought. The outcome was not reported as not recovered. There was no product quality complaint. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMRV
Symptoms: Agitation, Rash, Screaming
Clinical narrative: Information has been received from a father concerning his 15 month old female child with an egg allergy and peanut allergy who on 10-JUL-2006 was vaccinated subcutaneously with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot # unknown). On 10-JUL-2006, soon after getting the vaccine, the patient developed a rash. After being administered diphenhydramine hydrochloride (BENADRYL), the patient recovered. It was reported that the patient was "agitated and screaming" during the night of 12-JUL-2006. The outcome was reported as recovering. No product quality complaint was involved. Unspecified medical attention was sought. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood test, Pyrexia, Rash generalised, Vomiting
Clinical narrative: Information has been received from a health professional concerning a 4 year old male with asthma, reflux and unknown seasonal allergies, who on 12-APR-2006 was vaccinated with a dose of MMR II (Lot# 649807/0487R). Concomitant therapy included a dose of Dtp and a dose of poliovirus vaccine. It was reported that the patient developed vomiting, fever and a rash over his whole body after vaccination. The patient was taken to the emergency room and treated with intravenous fluids, TYLENOL, and another unspecified medication. The patient was hospitalized in the emergency room overnight. It was reported that the patient recovered. The reporter felt that the patient's reactions were other important medical events. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Laboratory test, Mumps, Vaccination failure
Clinical narrative: Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a dose of MMR II. Subsequently the patient developed a suspected case of mumps and was hospitalized for an unspecified amount of time. It was reported that "labwork" was done. No further information was available. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Adverse event
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with a dose of MMR II (lot # 653626/0426F). Subsequently, the patient experienced an adverse reaction. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Antibody test, Blood immunoglobulin G, Mumps
Clinical narrative: Information has been received from a physician concerning a 10 year old male who was vaccinated with a first and second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). It was reported that the patient was experiencing a possible case of mumps. It was noted that the patient was currently undergoing testing to determine if the experience was mumps. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning her son who "a couple of years ago," in approximately 2004, was vaccinated with MMR II. Subsequently, the patient developed a fever and rash. Unspecified medical attention was sought. At the time of the report the patient had recovered. There was no product quality complaint involved. The patient's brother (WAES#0607USA03942) had a similar experience following vaccination with MMR II. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning her son who on an unspecified date was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Subsequently the patient developed a fever and rash. It is unspecified if the patient recovered or if medical attention was sought. There was no product quality complaint involved. The patient's brother (WAES# 0607USA03670) had similar experience following vaccination with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Dizziness, Nausea, Rash
Clinical narrative: Information has been received from a registered nurse concerning an adult female who on 18-JUL-2006 was vaccinated SC with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) which expired on 03-JUL-2006. There was no concomitant medication. On 19-JUL-2006, also reported as "48 hours after being vaccinated" the patient developed nausea and dizziness. Unspecified medical attention was sought. At the time of the report the patient was recovering from the nausea and dizziness. It was also reported that the patient got "bumps" on her legs after receiving a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) when she was "young", these bumps have resolved. There was no product quality complaint involved. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Asthenia, Discomfort, Flushing, Heart rate, Heart rate increased
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old white male with no medical history or allergies who on 17-JUL-2006 was vaccinated with no medical history or allergies who on 17-JUL-2006 was vaccinated with a SC 0.5 mL second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Suspect vaccination included a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid, a dose of poliovirus vaccine and and a dose tuberculin purified protein derivative (MANTOUX SKIN TEST). It was reported that the patient seemed to be in pain or discomfort after he was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) or the diluent. The nurse administered a shot of what she thought was reconstituted measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) but shortly afterwards noticed the vial of unreconstituted measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). The nurse thought "maybe the diluent was given instead and the pain or discomfort could be related to the stinging of the diluen. Medical attention was sought. A urinary analysis was done, results not reported. The patients outcome was not reported. There was no product quality complaint involved. Follow-up information from the registered nurse indicated that "the week after 17-JUL-2006", on approximately 24-JUL-2006, the patient was vaccinated with the "proper dose" of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Within ten minutes of receiving the vaccination the child experienced a general rash with a flushing reaction. He was observed for a few hours. No treatment was required. The condition resolved. Follow-up information from the registered nurse indicated that the patient was on 21-JUL-2006 vaccinated SC in the left deltoid with the third dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (653751/0499F). There was no illness at the time of vaccination. In 21-JUl-2006, within 30 minutes of vaccination the patient returned to the office with a red rash all over and increased heart rate of 110. The patient felt weak. He was observed for several hours until resolved completely. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Pain, Rash generalised, Urine analysis
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old white male with no medical history or allergies who on 17-JUL-2006 was vaccinated with no medical history or allergies who on 17-JUL-2006 was vaccinated with a SC 0.5 mL second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Suspect vaccination included a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid, a dose of poliovirus vaccine and and a dose tuberculin purified protein derivative (MANTOUX SKIN TEST). It was reported that the patient seemed to be in pain or discomfort after he was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) or the diluent. The nurse administered a shot of what she thought was reconstituted measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) but shortly afterwards noticed the vial of unreconstituted measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). The nurse thought "maybe the diluent was given instead and the pain or discomfort could be related to the stinging of the diluen. Medical attention was sought. A urinary analysis was done, results not reported. The patients outcome was not reported. There was no product quality complaint involved. Follow-up information from the registered nurse indicated that "the week after 17-JUL-2006", on approximately 24-JUL-2006, the patient was vaccinated with the "proper dose" of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Within ten minutes of receiving the vaccination the child experienced a general rash with a flushing reaction. He was observed for a few hours. No treatment was required. The condition resolved. Follow-up information from the registered nurse indicated that the patient was on 21-JUL-2006 vaccinated SC in the left deltoid with the third dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (653751/0499F). There was no illness at the time of vaccination. In 21-JUl-2006, within 30 minutes of vaccination the patient returned to the office with a red rash all over and increased heart rate of 110. The patient felt weak. He was observed for several hours until resolved completely. Additional information is not expected.
Age: 1.5
Sex: F
Vaccine: MMR
Symptoms: Anaphylactic reaction, Angioedema, Body temperature increased, Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning an 18-month-old female with an egg allergy who on 06-MAR-2006, at 1000, was vaccinated SC with the first dose of MMR II. There was no illness at the time of vaccination. The physician reported that on 13-MAR-2006, the patient developed a fever of 102 and a rash. The patient was seen in the physician's office on 15-MAR-2006 as her fever and rash persisted. On 04-MAY-2006, the patient presented to the physician's office with angioedema, urticaria and anaphylaxis. 911 was called and the patient was seen in the Emergency Room (ER). Subsequently, the patient was hospitalized for recurrent angioedema, urticaria and rashes. At the time of this report, the patient was noted to be recovering. Additional information has been requested.
Age: 1.5
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning an 18-month-old female with an egg allergy who on 06-MAR-2006, at 1000, was vaccinated SC with the first dose of MMR II. There was no illness at the time of vaccination. The physician reported that on 13-MAR-2006, the patient developed a fever of 102 and a rash. The patient was seen in the physician's office on 15-MAR-2006 as her fever and rash persisted. On 04-MAY-2006, the patient presented to the physician's office with angioedema, urticaria and anaphylaxis. 911 was called and the patient was seen in the Emergency Room (ER). Subsequently, the patient was hospitalized for recurrent angioedema, urticaria and rashes. At the time of this report, the patient was noted to be recovering. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Mumps antibody test negative, No adverse reaction
Clinical narrative: Information has been received from a certified medical assistant (CMA) concerning a male physician who was vaccinated "three times" with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). The CMA reported that the physician subsequently failed to seroconvert for mumps all three times. Unspecified medical attention was sought and no other symptoms were noted. At the time of this report, the physician's mumps titer remained negative. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: MMR
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a nurse concerning a 4 year old child who, over the past month, in approximately July 2006, was vaccinated with MMRII. Concomitant therapy included Pediarix. Unspecified medical attention was sought. About 2 days after injection, in approximately July 2006, the patient experienced cellulitis at the injection site. About five days after injection, in approximately July 2006, the patient recovered. The reporting nurse also reported the experience of 4 other patients with MMR II (WAES# 0609USA00641, 0609USA00642, 0609USA00643, 0609USA00644). Additional information has been requested.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Drug exposure during pregnancy, Rash generalised, Urine human chorionic gonadotropin positive
Clinical narrative: Information has been received from a pharmacist concerning a 27 year old female with no known allergies who on 18 May 2006 was vaccinated with a dose of MMRII, there was no concomitant medication. At the time of the report the patient was "approximately three months pregnant", it was reported that the patient became pregnant at the end of April or early May 2006 with her last menstrual period being on 01 may 2006. Unspecified medical attention was sought. It was reported that the patient was not experiencing any problems. there was no product quality complaint involved. Additional information received from the patient indicated she was not aware of her pregnancy at the time of vaccination. "A couple weeks" after vaccination she developed a rash all over her body.  She was treated with steroids, which did not work and was then placed on stronger steroids. Subsequently the rash "cleared up". On an unspecified date the patient date the patient sought medical attention about things "being off in her body". A urine HCG pregnancy test was performed, and positive. She was unaware of her pregnancy until that time. Additional information is not available.
Age: 1.75
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Listless, Rash generalised
Clinical narrative: Information has been received from a consumer concerning his 21 month old daughter with no known allergies who in the Spring of 2006, was vaccinated with MMRII. There was no concomitant medication. In approximately April 2006, the patient experienced elevated temperature rash all over her body and was "listless". Unspecified medical attention was sought. The patient had unspecified bloodwork completed (results not reported). Subsequently, the patient recovered from elevated temperature, rash all over her body and being "listless". No further information is available.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Erythema, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old male who on 27 Jul 2006 was vaccinated with a dose of MMR II. Concomitant therapy included Havrix. On 07 Aug 2006 the patient developed red spots which were raised but no itching and no fever after vaccination with MMRII and Havrix. As of 08 Aug 2006, the patient had not recoverer. No additional information is expected.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test abnormal
Clinical narrative: Information has been received from a health professional concerning a 37 year old female who was vaccinated with MMRII when she was a child (no records available). On 13 Jul 2006, a titer for rubella was intermediate and was negative for mumps. The patient was considered to be not recovered from her experience. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a consumer concerning her 5 year old son who was vaccinated with MMRII. Concomitant therapy included DPT. Subsequently the patient experienced an allergic reaction. No other information was provided. Additional information is not expected.
Age: 29.0
Sex: M
Vaccine: DTOX, MMR
Symptoms: Body temperature increased, Pharyngolaryngeal pain, Pyrexia, Rash maculo-papular, Rash pruritic
Clinical narrative: Information has been received from a physician concerning a 29 year old male with no known allergies and a history of "class 2 TB" who on 28 Jul 2006 at 15:30 was vaccinated SC with a dose of MMR II, it was reported that the patient may have received a previous dose of the vaccine. Concomitant vaccination included a dose of DPT (manufacturer unspecified). There was no illness at the time of vaccination. On 11 Aug 2006, the patient presented to the physician's office with a few day history of slightly itchy maculopapular rash on his face and neck, a fever of 100 degreed F, and a sore throat. A white blood cell-viral count was performed: 5,700 (units unspecified), patient was diagnosed with viral exanthema vs. allergic reaction as the rash was itchy. The patient recovered don 13 Aug 2006. The patient returned on his own one month later and got another dose of MMRII and he "did fine". There was no product quality complaint involved. Additional information is not expected.
Age: 29.0
Sex: M
Vaccine: DTOX, MMR
Symptoms: Viral rash, White blood cell disorder
Clinical narrative: Information has been received from a physician concerning a 29 year old male with no known allergies and a history of "class 2 TB" who on 28 Jul 2006 at 15:30 was vaccinated SC with a dose of MMR II, it was reported that the patient may have received a previous dose of the vaccine. Concomitant vaccination included a dose of DPT (manufacturer unspecified). There was no illness at the time of vaccination. On 11 Aug 2006, the patient presented to the physician's office with a few day history of slightly itchy maculopapular rash on his face and neck, a fever of 100 degreed F, and a sore throat. A white blood cell-viral count was performed: 5,700 (units unspecified), patient was diagnosed with viral exanthema vs. allergic reaction as the rash was itchy. The patient recovered don 13 Aug 2006. The patient returned on his own one month later and got another dose of MMRII and he "did fine". There was no product quality complaint involved. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Adverse event
Clinical narrative: Information has been received from a licensed practical nurse concerning a child who on an unspecified date was vaccinated with a dose of MMR II. Subsequently the patient experienced an unknown adverse event. Unspecified medical attention was sought. No further information was available. There was no product quality complaint involved. No further information is available.
Age: 22.0
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Information has been received from a licensed practical nurse concerning a female who was 22 years old at the time of the report, who "as a child" was vaccinated with a dose of MMR II. Subsequently the patient developed redness and swelling at the injection site and 105 F fever. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Pruritus, Rash papular
Clinical narrative: Information has been received from a registered nurse concerning a 27 year old Hispanic female clinic employee with no allergies or medical history who on 15 Aug 2006 at 12:30 PM  was vaccinated SC in the right arm with a 0.5 mL dose of MMR II. Concomitant therapy included a tuberculin purified protein derivative test. On 17 Aug 2006, the employee developed itchy red papule spots on her trunk. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been received from a registered nurse who reported that on 17  Aug 2006, the patient reported red, itchy bumps on her abdomen, upper thigh, waistline, and buttocks. No diagnostic laboratory tests were performed. The patient recovered on an unspecified date. No further information is expected.
Age: 22.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, Seroconversion test negative
Clinical narrative: Information has been received from a registered nurse concerning a 22 year old female who was vaccinated with first and second doses of MMR II in May 2005 and on 04 May 2006 (lot# 649759/0383R), respectively. On 14 Aug 2006 a measles titer was taken and the result was negative, the patient did not seroconvert for measles. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Crying, Irritability
Clinical narrative: Information has been received from a registered nurse concerning a one year old male who was vaccinated "about 4 years ago" in approximately 2002 with a SC 0.5 mL dose of MMR II. It was reported that the child's mother stated that he was fussy and cried more often for several days post-vaccination. It was not reported if medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information from the registered nurse indicated that she did not have more information on this child. She stated that the child was more fussy after his vaccination with MMR II at one year of age. The mother was concerned about the child receiving the vaccine again. Additional information is not expected.
Age: 27.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a nurse concerning a 27 year old female with colitis ulcerative who was vaccinated with MMR II in the past (date not reported). A recent titer in 2006 showed non-immunity to mumps. Medical attention was sought. The patient's negative mumps titer persisted. Additional information has been requested.
Age: 1.25
Sex: M
Vaccine: MMR
Symptoms: Convulsion, Febrile convulsion, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 15 month old male with no known history or allergies who in approximately May 2002, was vaccinated SC with a dose of MMR II. There were no concomitant vaccinations or other concomitant therapy. Shortly after administration, the patient developed a high temperature and approximately 7-10 days later had a seizure. Additional information from the physician indicated that the patient experienced a febrile seizure post vaccination. The patient recovered shortly after the event. Unspecified medical attention was sought. There was no product quality complaint involved. Upon internal review the febrile seizure was determined to be an other important medical event. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: MMR
Symptoms: Seroconversion test negative
Clinical narrative: Information has been received from a medical assistant concerning a 24 year old female with no pertinent medical history and no drug reactions/allergies who in 1983 and 1991 was vaccinated with the first and second dose of MMR II. Subsequently the patient has not seroconverted for the measles component of the vaccine. This was discovered during routine blood work to check immunization titers. No other information was available at that time. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, Laboratory test, Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning an approximately 20 year old female with a history of infectious mononucleosis who on unspecified dates was vaccinated with two doses of MMR II. In "the past year," approximately 2006 the patient had a negative rubella titer. Unspecified medical attention was sought. No further information was available. There was no product quality complaint involved. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Idiopathic thrombocytopenic purpura
Clinical narrative: Information has been received from a physician concerning a 19 year old female who in 1988 was vaccinated with a dose of MMR II. In 1988, the patient experienced ITP symptoms and was admitted to the hospital. Subsequently, the patient recovered. Additional information has been requested.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Body temperature increased, Pyrexia, Rash
Clinical narrative: Information has been received from an office manager concerning a 42 year old white female with no allergies or medical history who on 16 Aug 2006 was vaccinated SC in the left arm with a 0.5 mL first dose of MMR II. There was no concomitant medication. There was no illness at the time of vaccination. On 26 Aug 2006, the patient developed a fever and a rash along the entire torso. Unspecified medical attention was sought. No diagnostic laboratory tests were performed. At the time of the report, the patient was recovering. The patient has no adverse events following prior vaccination. A product quality complaint was not involved. Additions information has been received from a medical assistant who reported that on 25 Aug 2006, the patient developed a rash on the limbs and trunk patient recovered on 30 Aug 2006. No further information is expected.
Age: 34.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a health professional concerning a 34 year old female with no medical history who "as a child" was vaccinated with a second dose of MMR II. There was no concomitant medication. A recent titer showed that she was not immune to mumps. No symptoms were noted. There was no product quality complaint involved. Additional information has been requested.
Age: 9.0
Sex: M
Vaccine: IPV, MMR
Symptoms: Diarrhoea, No adverse reaction, Vomiting
Clinical narrative: Information has been received from a registered nurse (R.N) concerning a 9-year-old male with no pertinent medical history or allergies, who on 28-AUG-2006 was vaccinated subcutaneously with one dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Secondary suspect vaccination given on the same day included a dose of poliovirus vaccine (manufacturer unknown). On 28-AUG-2006 the patient experienced vomiting and diarrhea shortly after administration. Unspecified medical attention was sought. Subsequently, it was reported that the patient recovered from vomiting and diarrhea on 29-AUG-2006. No product quality complaint was involved. Additional information has been received on 19-OCT-2006 reporting that it was determined that the adverse experiences were unrelated tot he vaccine. It was also reported that the patient received a second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) and there were no signs or symptoms of any adverse reactions.
Age: 7.0
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning a 20-year-old female with no allergies and a history of anemia who on 02-DEC-1987 and 01-AUG-1993 was vaccinated subcutaneously with a first and second dose of MMR II. The second dose was administered in the left arm and the lot # was 606866/0544W. On 22-JUL-2005 and 12-AUG-2005 the patient had IgG antibody titers that were negative for rubeola. Unspecified medical attention was sought. ON 22-AUG-2005, the patient received a third vaccination of MMR II 0.5 ml given subcutaneously in the right arm (lot # 647106/0793N). There was no illness at the time of vaccination. The LPN noted that concomitant medication at the time of the third vaccination included TRINESSA. Another IgG test was done on 25-AUG-2006 and results indicated that the patient was negative for rubeola and positive for mumps and rubella. Unspecified medical attention was sought. At the time of this report it was noted that the patient had "not recovered, not immune to rubeola." No product quality complaint was involved. The patient's vaccination records were reported as follows: diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unspecified) given on 08-AUG-1986, 07-OCT-1986, 09-DEC-1986, 03-JUN-1991 and a booster dose given on 02-JUL-2003 (0.5 ml dose given IM in the left arm lot # U0840AA); poliovirus vaccine inactivated (unspecified) given on 08-AUG-1986, 07-OCT-1986 and 02-DEC-1987; Hib conj vaccine (OMPC) (manufacturer unspecified) given on 10-JUN-1988; and hepatitis B virus vaccine rHBsAg (manufacturer unspecified) given on 27-MAR-1997, 28-MAY-1997 and 29-JUL-1998. Additional information is not expected.
Age: 11.0
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a certified medical assistant concerning an 11 year old female with an absent left kidney and an allergy to sulfa ear drops who on 31-AUG-2006 was vaccinated SC with a dose of MMR (lot# 649811/0491R). There was no concomitant medication. On 31-AUG-2006 the patient experienced injection site pain, redness and swelling. The patient was treated with ice and BENADRYL. On 31-AUG-2006, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: DTAPHEPBIP, MMR
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a nurse concerning a 4 year old child who, over the past month, in approximately July 2006, was vaccinated with MMR II. Concomitant therapy included PEDIARIX. Unspecified medical attention was sought. About 2 days after injection, in approximately July 2006, the patient experienced cellulitis at the injection site. About five days after injection, in approximately July 2006, the patient recovered. The reporting nurse also reported the experiences of 4 other patients with MMR II (WAES # 0607USA05076, 0609USA00642, 0609USA00643, 0609USA00644). Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: DTAPHEPBIP, MMR
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a nurse concerning a 4 year old child, over the past month, in approximately July 2006, was vaccinated with MMR. Concomitant therapy included PEDIARIX. Unspecified medical attention was sought. About 2 days after injection, in approximately July 2006, the patient experienced cellulitis at the injection site. About five days after injection, in approximately July 2006, the patient recovered. The reporting nurse also reported the experiences of 4 other patient with MMR (WAES # 0609USA00641, 0609USA05076, 0609USA00643, 0609USA00644). Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: DTAPHEPBIP, MMR
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a nurse concerning a 4 year old child who, over the past month, in approximately July 2006, was vaccinated with MMR. Concomitant therapy included PEDIARIX. Unspecified medical attention was sought. About 2 days after injection, in approximately July 2006, the patient experienced cellulitis at the injection site. About five days after injection, in approximately July 2006, the patient recovered. The reporting physician also reported the experiences of 4 other patients with MMR (WAES # 0609USA00641, 0609USA00642, 0607USA05076, 0609USA00644). Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: DTAPHEPBIP, MMR
Symptoms: Injection site cellulitis
Clinical narrative: Information has been received from a nurse concerning a 4 year old child who, over the past month, in approximately July 2006, was vaccinated with MMR. Concomitant therapy included PEDIARIX. Unspecified medical attention was sought. About 2 days after injection, in approximately July 2006, the patient experienced cellulitis at the injection site. About five days after injection, in approximately July 2006, the patient recovered. The reporting physician also reported the experiences of 4 other patients with MMR (WAES # 0609USA00641, 0609USA00642, 0607USA00643, 0609USA05076). Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Dyspnoea, Lethargy, Pyrexia
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an approximately 12-month-old female who on 24-SEP-2003 was vaccinated with a dose of MMR and a dose of Varivax. Subsequently, following vaccination the patient developed fever, lethargy and difficulty breathing. Unspecified medical attention was sought. There was no further information on this event. The patient also had another adverse experience following vaccination (WAES# 0609USA00465). Additional information has been requested.
Age: 28.0
Sex: M
Vaccine: MMR
Symptoms: Erythema, Incorrect route of drug administration, Injection site mass
Clinical narrative: Information has been received from a nurse concerning an approximately 28 year old male who on 11-SEP-2006, at around 17:00 p.m., was vaccinated subdermally with a 0.5 mL dose of MMR. It was reported that the licensed practical nurse who administered the vaccine "was thinking TB" instead of subcutaneous. Localized redness was noted at the time and a bump where injected. No other symptoms were noted. The patient was referred from the clinic to the emergency room, however the patient went home. Patient contact information was not available and the clinic was unable to follow up with him at home.
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a health professional concerning a female patient, with lupus, who may have been vaccinated with a dose of MMR. In 2000 titers were drawn and the patient had not developed antibodies. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 1.2
Sex: M
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning an approximately 18 year old male with no known drug allergies or medical history who in December 1989, was vaccinated with first dose of MMR. On 19-AUG-2006, the patient received his second dose of MMR. There was no concomitant medication. Subsequently the patient had a negative titer for rubella. No symptoms were reported. Additional information has been requested.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a certified medical assistant concerning an approximately 37 year old female who was vaccinated as a child with a dose of MMR II. Subsequently the patient was tested for immunity to measles, mumps and rubella recently for entry to nursing school. The patient tested positive for measles immunity, but was negative for mumps and indeterminate for rubella immunity. The office did not have the patient childhood vaccination record. Unspecified medical attention was sought. Additional information has been requested.
Age: 25.0
Sex: M
Vaccine: MMR
Symptoms: Fatigue, Malaise, Pyrexia, Rash
Clinical narrative: Information has been received from a nurse practitioner concerning a male with no pertinent medical history and no drug reactions/allergies who on 30-AUG-2006 was vaccinated SC with a first 0.5 mL dose of MMR (Lot # 651110/1048R). There was no concomitant medication or illness at the time of vaccination. On approximately 01-SEP-2006 (also reported as 14-SEP-2006) the patient experienced fatigue, malaise and fever. On 13-SEP-2006 (also reported as 14-SEP-2006) the patient developed a rash on his face, back, and chest. The reporter indicated that the patient "wasn't sure whether he was feeling tired since he has been surfing". Subsequently the patient recovered. It was also noted that the patient has never had any other vaccinations. There were no lab diagnostic studies performed. Unspecified medical attention was sought. No further information was available. There was no product quality complaint. Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a pharmacist concerning a female employee who was vaccinated with a first, second, and third dose of MMR, with the most recent being "6 months ago", in approximately March 2006. "Now", in 2006 the patient had a negative rubella titer. Unspecified medical attention was sought. No product quality complaint  as involved. No other information was provided. Additional information has been requested.
Age: 1.3
Sex: M
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a licensed practical nurse concerning a 15 month old male who on 02-JUL-1996 was vaccinated with a first dose of MMR. Subsequently, the patient developed hives "following the vaccination". Unspecified medical attention was sought. It was also reported that on 25-APR-2000 the patient was vaccinated with a dose of Varicella. Then on 01-MAY-2000 the patient was vaccinated with a second dose of MMR at a different office. No problems were reported with the second dose of MMR. No further information was available. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Abscess neck, Body temperature increased, Local swelling, Swelling face
Clinical narrative: Information has been received from a physician concerning a 12 month old male with no known medical history or allergies who on 22-SEP-2006 was vaccinated with a 0.5 mL IM dose of MMR (lot # 654235/0615F). Suspect vaccination administered that day included a dose of Varivax. On 26-SEP-2006 the patient developed swelling of the lower cheek of his face and of his neck. The physician indicated that this turned out to be an abscess unrelated to vaccination with MMR (lot # 654235/0615F). On 27-SEP-2006 the patient had a temperature of 102F. Medical attention was sought. It was reported that there was "no treatment thus far". The patient's outcome was not recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Injection site erythema, Injection site rash, Injection site reaction, Injection site swelling
Clinical narrative: Information has been received from a a licensed practical nurse concerning a 12 month old patient who was vaccinated on an unspecified date with a first dose of MMR. The nurse reported that the patient had an injection site reaction within one to two hours after vaccination. The reaction was described as swollen and red. No information on the duration of the rash was available. The nurse did not have first hand knowledge of the reaction since the vaccination was given at another office. Unspecified medical attention was sought. Follow-up has been received from the nurse, who reported that she spoke with the child's mother, and there is no additional information. No further information is expected.
Sex: U
Vaccine: MMR
Symptoms: Pain
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated with a dose of MMR. It was reported that the patient experienced slight stinging or a little pain. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Pyrexia, Rash morbilliform
Clinical narrative: Information has been received from a physician's assistant concerning a patient who was vaccinated with a dose of MMR II. Subsequently the patient developed a fever and a localized measles-like rash. Additional information is not expected.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning a 42 year old female who (in the past on an unspecified date) was vaccinated with MMR. In September 2006, the patient sought unspecified medical attention and underwent an antibody titer and had a negative mumps antibody. No other information was provided. Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: MMR
Symptoms: Mumps, Vaccination failure
Clinical narrative: Information has been received from a public health nurse concerning a 7 year old male patient who was vaccinated with a second dose of MMR II. The nurse reported that the patient may have mumps. Additional information has been requested.
Age: 40.0
Sex: F
Vaccine: MMR
Symptoms: Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a female approximately 40-year-old who on approximately 18-SEP-2006 was vaccinated with a dose of MMR. She developed a reaction to the vaccination starting one week after the vaccination on approximately 25-SEP-2006, the symptoms progressed to an area of swelling and tenderness with severe pain and induration at the site of injection at two weeks after the injection. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Unevaluable event
Clinical narrative: Information has been received from a mother regarding her daughter who was vaccinated with MMR II. Subsequently the patient experienced an unspecified reaction. No further information was available. No additional information is expected.
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a licensed practical nurse concerning an adult female with an intolerance to codeine who was vaccinated with MMR. There was no concomitant medication. Subsequently the patient did not show immunity to mumps. No symptoms were reported. Medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Age: 35.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a licensed practical nurse concerning an 35 year old female patient who was vaccinated with a second dose of MMR. There was no illness at the time of vaccination. It was reported that she did not show immunity to mumps. On 08-SEP-2006 a Mumps Abs, IgG was performed which was negative (<0.91). No symptoms were reported. Medical attention was sought. It was reported that the patient was re-vaccinated with MMR. There was no product quality complaint involved. Additional information is not expected.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a licensed practical nurse concerning a 30 year old female with no known allergies or pertinent medical history, who on an unspecified dates was vaccinated with first and second doses of MMR. There was no concomitant medication. Medical attention was sought. On 05-OCT-2006 blood was collected to test for measles, mumps, and rubella immunity. Lab results reported on 07-OCT-2006 indicated that the patient was immune to rubella with a serum rubella immunoglobulin antibody test of 13 IU/mL (>9 = immune) and measles with a serum measles immunoglobulin G antibody test of 1.99 (>1.09 = positive). The patient's serum mumps immunoglobulin G antibody test was <0.91 (<0.91 = negative/no immunity). No symptoms were reported. On an unspecified date the patient was re-vaccinated with a third dose of MMR. No further information was available. There was no product quality complaint involved. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Eye pruritus, Lacrimation increased, Nasal congestion
Clinical narrative: Information has been received from a physician concerning a 4-year-old male with a possible AUGMENTIN allergy and a history of drooling, runny nose and facial itching following vaccination with Varicella when he was 3 years of age (WAES# 0610USA04275), who was vaccinated with a dose of MMR. Subsequently, the patient developed a stuffy nose and itchy, watery eyes within minutes of receiving the vaccine. He was treated with BENADRYL. No outcome was reported. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, Inappropriate schedule of drug administration, Mumps antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a 22-year-old female who on 11-SEP-1085 and 09-JUL-1996 was vaccinated with the first and second doses of MMR II. During a pre-pregnancy screening, the patient had negative titers for measles, mumps, and rubella. No further information on the doses could be obtained. The patient has not had any problems with the negative titers. There was no additional information to report. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.